Let your confidence soar with Omnipod® 5
The power of the Pod
Podrick, our newest hero created in collaboration with Marvel Comics, transformed his diabetes management by switching to Omnipod 5. You can, too!
- Proactively helps correct highs and protect from lows1,2
- No more multiple daily injections or tangled tubes
- Over 80% Time in Range with optimised settings3
Designed to Simplify Life® with diabetes
Every hero needs the right support. With Omnipod® 5, Podrick can rely on automated insulin delivery and a tubeless design that removes daily hassle. The result? Less hassle, fewer interruptions, and more freedom to take on whatever comes next.
Take command with innovation
With Omnipod 5, the Pod and your compatible CGM sensor unite in dynamic communication. The CGM sensor sends glucose values and trends to the Pod to help the system make automated insulin delivery decisions every 5 minutes—helping to keep you in range.1,2
Meet our real-life heroes
Just like Podrick, our Podders are taking control. Here’s what they have to say about Omnipod® 5:
"When I first put Omnipod on, I felt free. There were no wires coming off me."
Lochlan
Podder® since 2023
Lochlan is a Sponsored Podder®
"Omnipod has helped me gain confidence in so many areas of my life, it makes me feel like I have something in my corner helping me every day."
Temi
Podder® since 2021
Temi is a Sponsored Podder®
"Omnipod was a game-changer for me. It empowered me and gave me back so much of my independence."
Sophie
Podder® since 2023
Sophie is a Sponsored Podder®
Request a Pod Experience Kit*
The Pod Experience Kit* is a real-feel, real-size, real-weight demo Pod, without the insulin, so you can get a feel for Omnipod in your daily routine. Experience the comfort and freedom of going tubeless. No needles, no commitment.
Please note that you should speak with your diabetes healthcare provider to assess your suitability for the Omnipod® 5.
* The Pod Experience Kit contains a needle-free Pod that does not deliver insulin. PDM/Controller is not included.
Visit https://www.omnipod.com/safety for the for complete safety information including indications, contraindications, warnings, cautions, and instructions.
1. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Average time with low blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 2.9% vs. 1.3%; 2.2% vs. 1.8%. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 in adults/adolescents and children = 64.7% vs. 73.9%; 52.5% vs. 68.0%.
2. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 39.4% vs. 29.5%. Average time with low blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 3.43% vs. 2.46%. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%.
3. Sawyer A, et al. Diabetes Technol Ther. 2026. Retrospective RWE of T1D users utilizing optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, and ≥5 bolus/day. Optimized settings: CF x TDI ≤1500 (83 mmol/L), I:C Ratio x TDI ≤350, Average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L).